Tag: Prescription Drugs
AHA: Dapagliflozin Noninferior to Placebo for MACE in T2DM
Treatment resulted in lower HF hospitalization rate in patients with, without atherosclerosis
AHA: Icosapent Ethyl Cuts CV Risk From Elevated Triglycerides
Ischemic events reduced among patients with elevated triglycerides despite taking statins
Improved Long-Term Pregnancy Outcomes for Goserelin + Chemo
Findings seen in premenopausal women with stage I to IIIA hormone receptor-negative breast cancer
Zoliflodacin Seems Effective for Some Gonococcal Infections
In phase 2 trial, oral dose treats urogenital, rectal infections; lower efficacy for pharyngeal infections
Buprenorphine/Samidorphan Helpful in Refractory Depression
Consistently greater reduction in MADRS score from baseline seen for BUP/SAM versus placebo
Most Meds Affecting Neurotransmitters Not Linked to Autism Risk
Prenatal exposure to 5 groups of meds had nominally significant links to ASD
ASN: Aggressive Control of BP, Lipids in T2DM May Up Kidney Risk
Strict BP control, fenofibrate use may increase long-term risk for adverse kidney events in T2DM patients
Second Hypertension Drug Recalled Due to Contamination
Some lots of irbesartan being recalled due to contamination with suspected carcinogen
First FDA-Approved Cannabis Drug Now Available in U.S.
Epidiolex is a twice-daily oral solution for use in patients with two types of epileptic syndromes
Antibiotics, Acid Suppressants in Infancy May Up Obesity Risk
Prescription of antibiotics, acid-suppressing meds in first two years of life linked to childhood obesity
